David Alland, MD, Infectious Disease, Newark, NJ, University Hospital

DavidAllandMD

Infectious Disease Newark, NJ

Professor, Medicine, UMDNJ-New Jersey Medical School

Dr. Alland is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alland's full profile

Already have an account?

Education & Training

  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineFellowship, Infectious Disease, 1988 - 1992
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusResidency, Internal Medicine, 1984 - 1987
  • Columbia University College of Physicians & Surgeons
    Columbia University College of Physicians & SurgeonsClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2019
  • VA State Medical License
    VA State Medical License 2017 - 2020
  • TX State Medical License
    TX State Medical License 2017 - 2018
  • NJ State Medical License
    NJ State Medical License 2001 - 2023
  • NY State Medical License
    NY State Medical License 1994 - 2017
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, W Henry Boom, The New England Journal of Medicine
  • Bacterial Factors That Predict Relapse After Tuberculosis Therapy  
    David Alland, MD, The New England Journal of Medicine

Press Mentions

  • Latest Features
    Latest FeaturesOctober 23rd, 2020
  • Explainer: COVID-19 Testing, Testing, One, Two, Three…
    Explainer: COVID-19 Testing, Testing, One, Two, Three…April 30th, 2020
  • Rutgers Researchers Evaluate New Rapid COVID-19 Test
    Rutgers Researchers Evaluate New Rapid COVID-19 TestMarch 23rd, 2020
  • Join now to see all

Grant Support

  • On Demand Blood Tests For Select Agent DiagnosisNational Institute Of Allergy And Infectious Diseases2012
  • Development Of A Second Generation Mdr-Xdr TB AssayNational Institute Of Allergy And Infectious Diseases2009–2012
  • Rapid Diagnosis Of XDR TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Development Of A Molecular Blood CultureNational Institute Of Allergy And Infectious Diseases2009–2010
  • Afb Smears For Drug Resistance Detection And Surveillance In MTB.National Institute Of Allergy And Infectious Diseases2009–2010
  • Integrated Dual-Use Systems For Bio-Defense &Sepsis DiagnosisNational Institute Of Allergy And Infectious Diseases2007–2010
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2006–2008
  • Detection Of Select Agents In Single-Well AssaysNational Institute Of Allergy And Infectious Diseases2003–2007
  • Towards Drugs That Prevent Resistance To The HIV Oi, TBNational Institute Of Allergy And Infectious Diseases2005–2006
  • Tuberculosis Genotyping And Evolutionary ConsortiumNational Institute Of Allergy And Infectious Diseases2002–2005
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2004
  • Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2002
  • Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2000–2001
  • Tuberculosis Curriculum For An Urban Medical CenterNational Heart, Lung, And Blood Institute1997–2000

Hospital Affiliations